These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25428709)

  • 41. The Role of the Endocannabinoid System in Binge Eating Disorder.
    Bourdy R; Befort K
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SipNose-topiramate: a potential novel approach to binge eating management.
    Kobo-Greenhut A; Zohar-Beja A; Hadar L; Itzhaki L; Karasik A; Caraco Y; Frankenthal H; Shahaf D; Ekstein D; Shichor I; Gur E
    J Eat Disord; 2023 Jun; 11(1):102. PubMed ID: 37365668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topiramate for binge-eating disorder associated with obesity.
    Tata AL; Kockler DR
    Ann Pharmacother; 2006 Nov; 40(11):1993-7. PubMed ID: 17047134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binge eating disorder and obesity.
    de Zwaan M
    Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S51-5. PubMed ID: 11466589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The epidemiology and genetics of binge eating disorder (BED).
    Davis C
    CNS Spectr; 2015 Dec; 20(6):522-9. PubMed ID: 26258270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binge Eating Disorder: A Psychiatrist's Commentary on Clinical Considerations.
    Citrome L
    Clin Ther; 2021 Jan; 43(1):7-16. PubMed ID: 33308878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel treatment options of binge eating disorder.
    Marazziti D; Rossi L; Baroni S; Consoli G; Hollander E; Catena-Dell'Osso M
    Curr Med Chem; 2011; 18(33):5159-64. PubMed ID: 22050761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different moderators of cognitive-behavioral therapy on subjective and objective binge eating in bulimia nervosa and binge eating disorder: a three-year follow-up study.
    Castellini G; Mannucci E; Lo Sauro C; Benni L; Lazzeretti L; Ravaldi C; Rotella CM; Faravelli C; Ricca V
    Psychother Psychosom; 2012; 81(1):11-20. PubMed ID: 22116257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonnormative eating behavior and psychopathology in prebariatric patients with binge-eating disorder and night eating syndrome.
    Baldofski S; Tigges W; Herbig B; Jurowich C; Kaiser S; Stroh C; de Zwaan M; Dietrich A; Rudolph A; Hilbert A
    Surg Obes Relat Dis; 2015; 11(3):621-6. PubMed ID: 25887494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics.
    Boswell RG; Potenza MN; Grilo CM
    Clin Ther; 2021 Jan; 43(1):50-69. PubMed ID: 33257092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binge antecedents in obese women with and without binge eating disorder.
    Greeno CG; Wing RR; Shiffman S
    J Consult Clin Psychol; 2000 Feb; 68(1):95-102. PubMed ID: 10710844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychological and dietary treatments of binge eating disorder: conceptual implications.
    Wonderlich SA; de Zwaan M; Mitchell JE; Peterson C; Crow S
    Int J Eat Disord; 2003; 34 Suppl():S58-73. PubMed ID: 12900987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative Effectiveness of Treatments for Binge-Eating Disorder: Systematic Review and Network Meta-Analysis.
    Peat CM; Berkman ND; Lohr KN; Brownley KA; Bann CM; Cullen K; Quattlebaum MJ; Bulik CM
    Eur Eat Disord Rev; 2017 Sep; 25(5):317-328. PubMed ID: 28467032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implicit cognitive processes in binge-eating disorder and obesity.
    Brauhardt A; Rudolph A; Hilbert A
    J Behav Ther Exp Psychiatry; 2014 Jun; 45(2):285-90. PubMed ID: 24480398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of rimonabant in obese patients with binge eating disorder.
    Pataky Z; Gasteyger C; Ziegler O; Rissanen A; Hanotin C; Golay A
    Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):20-6. PubMed ID: 23147209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Piracetam attenuates binge eating disorder related symptoms in rats.
    Hussain Y; Krishnamurthy S
    Pharmacol Biochem Behav; 2018 Jun; 169():35-47. PubMed ID: 29654794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.
    van Gestel MA; Kostrzewa E; Adan RA; Janhunen SK
    Br J Pharmacol; 2014 Oct; 171(20):4767-84. PubMed ID: 24866852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disulfiram for binge eating disorder: an open trail.
    Farci AM; Piras S; Murgia M; Chessa A; Restivo A; Gessa GL; Agabio R
    Eat Behav; 2015 Jan; 16():84-7. PubMed ID: 25464072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A model of binge-like eating behavior in mice that does not require food deprivation or stress.
    Czyzyk TA; Sahr AE; Statnick MA
    Obesity (Silver Spring); 2010 Sep; 18(9):1710-7. PubMed ID: 20300082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Register-Based Case-Control Study of Prescription Medication Utilization in Binge-Eating Disorder.
    Watson HJ; Jangmo A; Munn-Chernoff MA; Thornton LM; Welch E; Wiklund C; von Hausswolff-Juhlin Y; Norring C; Herman BK; Larsson H; Bulik CM
    Prim Care Companion CNS Disord; 2016 Jul; 18(4):. PubMed ID: 27828693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.